STEPHENSON BRIAN C

CIK 00017800301 companyPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001780030

Recent Transactions

50 trades

Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-02-25$33.18/sh−8,400→ 102,564 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-02-25$34.18/sh−100→ 102,464 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2025-02-25−8,500→ 440,170 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-02-25$17.00/sh+8,500→ 110,964 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-02-19$36.16/sh−4,148→ 102,464 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2025-02-16−6,705→ 80,459 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2025-02-16−17,368→ 138,947 total
Tax Payment
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-02-16$34.90/sh−13,102→ 106,612 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-02-16+25,798→ 119,714 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2025-02-16−779→ 0 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2025-02-16−946→ 2,840 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-01-28$17.00/sh+68,000→ 161,758 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-01-28$36.29/sh−68,000→ 93,758 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2025-01-28−68,000→ 448,670 total
Award
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2024-12-10+42,683→ 42,683 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2024-11-19$22.41/sh−4,156→ 93,758 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2024-11-16−778→ 779 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2024-11-16−17,369→ 156,315 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2024-11-16−947→ 3,786 total
Tax Payment
BridgeBio Pharma, Inc.$BBIO
Common Stock
2024-11-16$23.72/sh−13,077→ 97,914 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2024-11-16+25,799→ 110,991 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2024-11-16−6,705→ 87,164 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2024-08-19$25.13/sh−1,698→ 85,192 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2024-08-19$24.39/sh−2,457→ 86,890 total
Tax Payment
BridgeBio Pharma, Inc.$BBIO
Common Stock
2024-08-16$24.40/sh−13,077→ 89,347 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2024-08-16+25,797→ 102,424 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2024-08-16−17,368→ 173,684 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2024-08-16−6,705→ 93,869 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2024-08-16−946→ 4,733 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2024-08-16−778→ 1,557 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2024-05-16−17,368→ 191,052 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2024-05-16−778→ 2,335 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2024-05-16−1,710→ 0 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2024-05-16−6,704→ 100,574 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2024-05-16−947→ 5,679 total
Tax Payment
BridgeBio Pharma, Inc.$BBIO
Common Stock
2024-05-16$31.04/sh−13,943→ 76,472 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2024-05-16+27,507→ 90,415 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2024-03-12+15,442→ 15,442 total
Award
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2024-03-12+107,278→ 107,278 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2024-02-16−17,369→ 208,420 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2024-02-16−24,193→ 0 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2024-02-16−778→ 3,113 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2024-02-16−1,710→ 1,710 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2024-02-16+44,996→ 81,827 total
Tax Payment
BridgeBio Pharma, Inc.$BBIO
Common Stock
2024-02-16$37.21/sh−18,919→ 62,908 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2024-02-16−946→ 6,626 total
Sale
BridgeBio Pharma, Inc.$BBIO
Common Stock
2023-11-17$29.10/sh−22,685→ 36,710 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2023-11-16−24,193→ 24,193 total
Tax Payment
BridgeBio Pharma, Inc.$BBIO
Common Stock
2023-11-16$28.86/sh−22,311→ 59,395 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2023-11-16−947→ 7,572 total

Companies

BridgeBio Pharma, Inc.
Secretary, Treasurer & CFO
$BBIO

Recent Filings

Address

C/O BRIDGEBIO PHARMA, INC. 3160 PORTER DR., SUITE 250

PALO ALTO, CA, 94304

View on SEC.gov